Shizuoka, Japan

Masaaki Ohta

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaaki Ohta. Retrieved from https://idiyas.com/inventor/masaaki-ohta-c9b36cej

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masaaki Ohta: Innovator in Pharmaceutical Composition

Introduction

Masaaki Ohta is a notable inventor based in Shizuoka-ken, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and safety of pharmaceutical compositions.

Latest Patents

Masaaki Ohta holds a patent for an acylated cyclodextrin-containing pharmaceutical composition. This composition is designed for trans-mucosal or transdermal administration, utilizing a per-C.sub.2-18 acylated cyclodextrin as a drug reservoir or carrier. The formulation is recognized for its safety and excellent drug release behavior, making it a valuable advancement in pharmaceutical technology.

Career Highlights

Ohta is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to contribute to the development of innovative solutions that address various medical needs. His expertise in drug formulation has positioned him as a key player in the field.

Collaborations

Masaaki Ohta has collaborated with esteemed colleagues such as Kaneto Uekama and Fumitoshi Hirayama. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Masaaki Ohta's contributions to pharmaceutical compositions highlight his innovative spirit and dedication to improving drug delivery systems. His work continues to influence the field, paving the way for safer and more effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…